🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fluoropyrimidine chemotherapy agents , such as 5-fluorouracil and capecitab...
Status
Terminated
Location
Helsinki University Central Hospital
Start Date
2015-01
Trial ID
NCT02216149
Treatments Being Tested
This study includes two parts:Part 1: SSGJ-707 (different dosing regimens) ...
Status
Recruiting
Location
Liu Tianshu
Start Date
2024-09-03
Trial ID
NCT06493760
Treatments Being Tested
This study is a multicenter, randomized, open-label, controlled Phase III c...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-05-28
Trial ID
NCT07584135
The investigators compare the overall survival between combination chemothe...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2014-02
Trial ID
NCT02114359
This study aims to elucidate the regression effects of neoadjuvant chemothe...
Status
Recruiting
Location
Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-08
Trial ID
NCT05914389
Treatments Being Tested
This is an open-label, prospective, multicenter phase II clinical trial to ...
Status
Recruiting
Location
Sir Run Run Shao hospital
Start Date
2023-08-02
Trial ID
NCT05972655
Treatments Being Tested
XELOX (Capecitabine and Oxaliplatin) is an effective and convenient regimen...
Status
Completed
Location
Department of Oncology, Esbjerg Hospital
Start Date
2004-02
Trial ID
NCT00212615
Treatments Being Tested
This is a prospective, multicenter, single-arm, open-label study. The main ...
Status
Recruiting
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2023-10-18
Trial ID
NCT06389760
Treatments Being Tested
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
Research objective: To compare the efficacy and safety of Capox + Bev versu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07383285